logo

For the Inventor, By the Inventor

Dallas, TX, United States of America

Haribabu Ankati

This inventor holds 5 USPTO granted patents. Top assignees: Southern Methodist University, The University of Texas System. Active years: 2014-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haribabu Ankati. Retrieved from https://idiyas.com/inventor/haribabu-ankati

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

Average Co-Inventor Count = 3.2

ph-index = 1


Company Filing History:

goldMedal5 out of 119 
 
Southern Methodist University
 patents
silverMedal1 out of 5,633 
 
The University of Texas System
 patents
where one patent can have more than one assignee

Years Active: 2014-2018

Loading Chart...
5 patents (USPTO):Explore Patents
1. 10093681 - Compounds and derivatives of 2H-pyrido (3,2-b)(1, 4) oxazin 3)4H)-ones as raf kinase and LRRK2 inhibitors (2018-10-09),
2. 9567305 - Quinoxaline compounds and derivatives (2017-02-14),
3. 9493452 - Compounds and derivatives of 2H-pyrido (3,2-b)(1, 4) oxazin 3)4H)-ones as raf kinase and LRRK2 inhibitors (2016-11-15),
4. 8680094 - 1, 4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions (2014-03-25),
5. 8669363 - Quinoxaline compounds and derivatives (2014-03-11),

Title: Haribabu Ankati: Innovator in Pharmaceutical Compounds

Introduction

Haribabu Ankati is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of pharmaceutical compounds, holding a total of 5 patents. His work focuses on innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, Ankati has developed compounds and derivatives of 2H-pyrido (3,2-b)(1, 4) oxazin 3)4H)-ones as RAF kinase and LRRK2 inhibitors. This invention provides oxazine compounds, methods of using them, and methods of making these compounds for pharmaceutical use. Additionally, he has worked on quinoxaline compounds and derivatives, which also include methods of use and production for pharmaceutical applications.

Career Highlights

Ankati has had a distinguished career, working with reputable institutions such as Southern Methodist University and the University of Texas System. His research and innovations have contributed to advancements in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Edward R. Biehl and Sukanta Kamila, who have collaborated with him on various projects.

Conclusion

Haribabu Ankati's contributions to the field of pharmaceutical compounds highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to developing new therapeutic options that can benefit society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…